Infectious Diseases Search
Infectious Diseases Infectious Diseases
febrile%20neutropenia
FEBRILE NEUTROPENIA
Febrile neutropenia is having a fever of ≥38.3 ºC or ≥38 ºC over an hour and neutropenia that is having an absolute neutrophil count (ANC) of <500 neutrophils/mm3 or an ANC <1000 neutrophils/mm3 expected to decline to ≤500 neutrophils/mm3 over the next 48 hours.
The risk of febrile neutropenia is directly proportional to the duration and severity of neutropenia.
Fever is frequently the only indication of infection in the neutropenic patient.
Drug Information

Indication: Short-term treatment of upper & lower resp tract, skin & soft tissue, GUT infections. Tab & inj Sh...

Indication: Lower resp tract, complicated & uncomplicated UTI, intra-abdominal, skin & skin structure infections; ...

Indication: Invasive aspergillosis; fluconazole-resistant serious invasive Candida infections (eg, C krusei); serious...

Indication: Nosocomial & community-acquired pneumonia including concurrent bacteremia, complicated & uncomplicated...

Indication: For adult & childn ≥12 mth: Empirical therapy for presumed fungal infections in febrile, neutropenic pa...

Indication: Cryptococcal meningitis & infections at other sites (eg, pulmonary, cutaneous). Prevention of cryptococcal...

Indication: Reduction in duration of neutropenia & incidence of febrile neutropenia in patients treated w/ established...

Indication: Upper & lower resp tract, skin & soft tissue, GUT, bone & joint infections.

Dosage: Cap Gynaecological: Vulvovag candidiasis 200 mg bd for 1 day or 200 mg once daily for 3 days. Dermatological/O

Indication: Polymicrobic & mixed aerobic/anaerobic infections. Initial therapy prior to the identification of the caus...

1  /  12
1  /  12
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Sex without condoms for high school girls on long-acting contraception
Kavitha G. Shekar, 23 Mar 2016
High school girls (15 to 19 years) on long-acting reversible contraception (LARC) are 60 percent less likely to use condoms compared to contraceptive pill users, findings of a US-based study. This places these girls and their partners at a higher risk for sexually transmitted infections (STIs) including human immunodeficiency virus and reflects their ignorance that condoms are mainly used for pregnancy prevention.